Report Highlights
A recent market study published by Future Market Insights (FMI) on the PD1/PDL1 inhibitors market offers global industry analysis for 2015-2019 & opportunity assessment for 2020-2030. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the PD1/PDL1 inhibitors market, growth prospects of the market are obtained with maximum precision.
The report features unique and salient factors that may make a huge impact on the development of the PD1/PDL1 inhibitors market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the PD1/PDL1 inhibitors market in the coming years. The report provides detailed information about the current and future growth prospects of the PD1/PDL1 inhibitors market in the most comprehensive way for better understanding of readers.
Key Segments of PD1/PDL1 inhibitors Market
FMI’s study on the PD1/PDL1 inhibitors market offers information divided into four important segments-product type, indication, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Product
- Nivolumab
- Pembrolizumab
- Atezolizumab
- Avelumab
- Durvalumab
Indication
- Melanoma
- Non-Small Cell Lung Cancer (NSCLC)
- Renal Cell Carcinoma (RCC)
- Head and Neck Squamous Cell Cancer (HNSCC)
- Bladder Cancer
- Merkel Cell Carcinoma (MCC)
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Region
- North America
- Latin America
- Europe
- South Asia & Pacific
- East Asia
- Middle East and Africa
Report Chapters
Chapter 1 – Executive Summary
The report commences with the executive summary of the PD1/PDL1 inhibitors market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the PD1/PDL1 inhibitors market as well as the key trends impacting the market.
Chapter 2 – Market Overview
Readers can find detailed taxonomy and product definition of the PD1/PDL1 inhibitors market, in this chapter, which help readers understand basic information about PD1/PDL1 inhibitors.
Chapter 3 – Key Market Trends
This section highlights the key trends impacting the PD1/PDL1 inhibitors market, which will help readers understand the current trends and their impact on market growth.
Chapter 4 – Global PD1/PDL1 inhibitors Market Value (US$) Analysis 2015-2019 and Forecast 2020-2030
This section explains the global market value analysis and forecast for the PD1/PDL1 inhibitors market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030).
Chapter 5 – Market Background
This chapter explains the key macroeconomic factors that are expected to influence the growth of the PD1/PDL1 inhibitors market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. This section also provides knowledge about value chain analysis of the market. Besides, it provides key dynamics of the PD1/PDL1 inhibitors market, which include the drivers, restraints, and opportunity analysis. This chapter is expected to enable readers to understand the factors that are propelling the growth of the PD1/PDL1 inhibitors market, as well as those that are likely to hamper the growth of the PD1/PDL1 inhibitors market. The opportunity analysis for the PD1/PDL1 inhibitors will help readers understand the market opportunities, based on which they can plan their strategies.
In addition this section also provides the current and expected impact of COVID19 on the PD1/PDL1 inhibitors market.
Chapter 6 – Global PD1/PDL1 inhibitors Market Analysis (2015-2019) & Opportunity Assessment (2020-2030), By Product Type
Based on product type, the PD1/PDL1 inhibitors market is segmented into nivolumab, pembrolizumab, atezolizumab, avelumab and durvalumab. In this chapter, readers can find information about a detailed analysis of the market by different product type of PD1/PDL1 inhibitors and their growth over the forecast period.
Chapter 07 – Global PD1/PDL1 inhibitors Market Analysis 2015-2019 & Opportunity Assessment, 2020-2030, By Indication
Based on indication, the PD1/PDL1 inhibitors market is segmented into Melanoma, Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC), Head and Neck Squamous Cell Cancer (HNSCC), Bladder Cancer, Merkel Cell Carcinoma (MCC) and Others. In this chapter, readers can find information on market attractive analysis based on indication.
Chapter 08 – Global PD1/PDL1 inhibitors Market Analysis 2015-2019 & Opportunity Assessment, 2020-2030, By Distribution Channel
Based on distribution channel, the PD1/PDL1 inhibitors market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. In this chapter, readers can find information on market attractive analysis based on distribution channel.
Chapter 09 – Global PD1/PDL1 inhibitors Market Analysis 2015-2019 & Opportunity Assessment 2020-2030, By Region
This chapter explains how the PD1/PDL1 inhibitors market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).
Chapter 10 – North America PD1/PDL1 inhibitors Market Analysis 2015-2019 & Opportunity Assessment 2020-2030
This chapter includes a detailed analysis of the growth of the North America PD1/PDL1 inhibitors market along with the country-wise assessment including the U.S. and Canada. Readers can also find key takeaways of this region, and market growth based on product type, consumption, and country of PD1/PDL1 inhibitors in the North American region.
Chapter 11 – Latin America PD1/PDL1 inhibitors Market Analysis 2015-2019 & Opportunity Assessment 2020-2030
This chapter includes the growth prospects of the PD1/PDL1 inhibitors market in leading countries such as Brazil, Mexico, and the rest of Latin America. Readers can find thorough information about the growth parameters of the Latin America PD1/PDL1 inhibitors market during 2020-2030.
Chapter 12 –Europe PD1/PDL1 inhibitors Market Analysis 2015-2019 & Opportunity Assessment 2020-2030
Important growth prospects of the PD1/PDL1 inhibitors market based on product type, consumption, and country in several European countries such as the U.K., Germany, France, Italy, Spain, Russia, BENELUX, and Rest of Europe are included in this chapter.
Chapter 13 – South Asia PD1/PDL1 inhibitors Market Analysis 2015-2019 and Forecast 2020-2030
India, Indonesia, Malaysia, Thailand, and the rest of South Asia are the leading countries/regions in South Asia that are the prime subjects of assessment to obtain the growth prospects of the South Asia PD1/PDL1 inhibitors market, in this chapter, readers can find thorough information about the growth parameters of the South Asia PD1/PDL1 inhibitors market during 2030.
Chapter 14 – East Asia PD1/PDL1 inhibitors Market Analysis 2015-2019 and Forecast 2020-2030
Detailed information about factors such as incremental opportunity, Y-O-Y growth, and regional trends that are impacting the growth of the East Asia PD1/PDL1 inhibitors market are included in this chapter. It also includes the growth prospects of the PD1/PDL1 inhibitors market in leading East Asian countries such as China, Japan, and South Korea.
Chapter 15 – Oceania PD1/PDL1 inhibitors Market Analysis 2014–2018 and Forecast 2020–2030
This chapter consists of important parameters that have a huge impact on the growth of the PD1/PDL1 inhibitors market in Oceania, based on market segmentation, during the forecast period. The chapter also provides an overview of the drivers, restraints, and trends in the Oceania PD1/PDL1 inhibitors market.
Chapter 16 – MEA PD1/PDL1 inhibitors Market Analysis 2015-2019 & Opportunity Assessment 2020-2030
This chapter provides information on how the PD1/PDL1 inhibitors market will grow in the major countries in MEA region, such as GCC Countries, South Africa, Northern Africa, Turkey and Rest of MEA during 2020-2030.
Chapter 17 – MEA PD1/PDL1 inhibitors Market Analysis 2015-2019 & Opportunity Assessment 2020-2030
This chapter provides information on how the PD1/PDL1 inhibitors market will grow in the major countries across the world during 2020-2030.
Chapter 18 – Market Structure Analysis
This chapter covers the market analysis of competitors based on revenue tiers, single point view of portfolio across industry segments, and their relative market position.
Chapter 19 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the PD1/PDL1 inhibitors market, along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Players featured in the PD1/PDL1 inhibitors market report include Bristol-Myers Squibb, Merck & Co., Inc., F. Hoffmann-La Roche AG, AstraZeneca, Merck KGaA & Pfizer Inc.
Chapter 20– Assumptions and Acronyms Used
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.
Chapter 21 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the PD1/PDL1 inhibitors market.
Sources and Primary Research Splits (%)
Industry Interactions
Key Designations
- C - Level Executives
- Marketing Directors
- Product Managers
- Business Development Officers
- Production Managers
- Procurement Heads
- Sales Executives
Stakeholder
- Distributors
- Traders
- Raw Material Suppliers
- Industry Experts
- Consumptions
Key Questions
- Current Market Dynamics and Challenges
- Yesteryear Trends
- Market Characteristics
- Market Performance and Growth Quadrants
- Competition Structure and Market Structure
- Strategic Growth Initiatives
- Near-term and Long-term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
References Catalogue
- Industry Publications
- World Health Organizations (WHO)
- National Institute of Health (NIH)
- Factiva
- Company Press Releases
- Annual Reports and Investor Presentations
- Research Papers
- Government Websites and Publications
- Company Websites,
- Morningstar
- Table 1 : Global PD1/PDL1 Inhibitors Market Analysis 2015-2019 and Forecast 2020-2030, By Product Type
- Table 2 : Global PD1/PDL1 Inhibitors Market Analysis 2015-2019 and Forecast 2020-2030, By Indication
- Table 3 : Global PD1/PDL1 Inhibitors Market Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
- Table 4 : Global PD1/PDL1 Inhibitors Market Analysis 2015-2019 and Forecast 2020-2030, By Region
- Table 5 : North America PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
- Table 6 : North America PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
- Table 7 : North America PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
- Table 8 : North America PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
- Table 9 : Latin America PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
- Table 10 : Latin America PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
- Table 11 : Latin America PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
- Table 12 : Latin America PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
- Table 13 : Europe PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
- Table 14 : Europe PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
- Table 15 : Europe PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
- Table 16 : Europe PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
- Table 17 : South Asia PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
- Table 18 : South Asia PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
- Table 19 : South Asia PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
- Table 20 : South Asia PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
- Table 21 : East Asia PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
- Table 22 : East Asia PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
- Table 23 : East Asia PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
- Table 24 : East Asia PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
- Table 25 : Oceania PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
- Table 26 : Oceania PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
- Table 27 : Middle East and Africa PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
- Table 28 : Middle East and Africa PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
- Table 29 : Middle East and Africa PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Indication
- Table 30 : Middle East and Africa PD1/PDL1 Inhibitors Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
- Figure 1 : Global PD1/PDL1 Inhibitors Market Value Analysis, 2015-2019
- Figure 2 : Global PD1/PDL1 Inhibitors Market Forecast & Y-o-Y Growth, 2020-2030
- Figure 3 : Global PD1/PDL1 Inhibitors Market Absolute $ Opportunity (US$ Mn) Analysis, 2019-2030
- Figure 4 : Global PD1/PDL1 Inhibitors Market Y-o-Y Growth (%) Analysis, 2019-2030
- Figure 5 : Global PD1/PDL1 Inhibitors Market Value Share (%) Analysis 2020 & 2030, By Product Type
- Figure 6 : Global PD1/PDL1 Inhibitors Market Y-o-Y Growth (%) Analysis 2019-2030, By Product Type
- Figure 7 : Global PD1/PDL1 Inhibitors Market Attractiveness Analysis 2020-2030, By Product Type
- Figure 8 : Global PD1/PDL1 Inhibitors Market Value Share (%) Analysis 2020 & 2030, By Indication
- Figure 9 : Global PD1/PDL1 Inhibitors Market Y-o-Y Growth (%) Analysis 2019-2030, By Indication
- Figure 10 : Global PD1/PDL1 Inhibitors Market Attractiveness Analysis 2020-2030, By Indication
- Figure 11 : Global PD1/PDL1 Inhibitors Market Value Share (%) Analysis 2020 & 2030, By Distribution Channel
- Figure 12 : Global PD1/PDL1 Inhibitors Market Y-o-Y Growth (%) Analysis 2019-2030, By Distribution Channel
- Figure 13 : Global PD1/PDL1 Inhibitors Market Attractiveness Analysis 2020-2030, By Distribution Channel
- Figure 14 : Global PD1/PDL1 Inhibitors Market Value Share (%) Analysis 2020 & 2030, By Region
- Figure 15 : Global PD1/PDL1 Inhibitors Market Y-o-Y Growth (%) Analysis 2019-2030, By Region
- Figure 16 : Global PD1/PDL1 Inhibitors Market Attractiveness Analysis 2020-2030, By Region
- Figure 17 : North America PD1/PDL1 Inhibitors Market Value Analysis, 2015-2019
- Figure 18 : North America PD1/PDL1 Inhibitors Market Forecast & Y-o-Y growth, 2020-2030
- Figure 19 : North America PD1/PDL1 Inhibitors Market Attractiveness Analysis, By Product Type
- Figure 20 : North America PD1/PDL1 Inhibitors Market Attractiveness Analysis, By Indication
- Figure 21 : North America PD1/PDL1 Inhibitors Market Attractiveness Analysis, By Distribution Channel
- Figure 22 : North America PD1/PDL1 Inhibitors Market Attractiveness Analysis, By Country
- Figure 23 : Latin America PD1/PDL1 Inhibitors Market Value Analysis, 2015-2019
- Figure 24 : Latin America PD1/PDL1 Inhibitors Market Forecast & Y-o-Y growth, 2020-2030
- Figure 25 : Latin America PD1/PDL1 Inhibitors Market Attractiveness Analysis, By Product Type
- Figure 26 : Latin America PD1/PDL1 Inhibitors Market Attractiveness Analysis, By Indication
- Figure 27 : Latin America PD1/PDL1 Inhibitors Market Attractiveness Analysis, By Distribution Channel
- Figure 28 : Latin America PD1/PDL1 Inhibitors Market Attractiveness Analysis, By Country
- Figure 29 : Europe PD1/PDL1 Inhibitors Market Value Analysis, 2015-2019
- Figure 30 : Europe PD1/PDL1 Inhibitors Market Forecast & Y-o-Y growth, 2020-2030
Future Market Insights is the premier provider of market intelligence and consulting services, serving client in over 160 countries. FMI is headquartered in London, the global financial capital and has delivery centers in the U.S. and India. FMI's research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure that our clients prepare for the evolving needs of their customers. FMI's team of over 200 research analysts provides market intelligence at global, regional, and country levels. Our analysts are committed to provide independent insights, relying on our cognitive training modules, which conditions them to look at data objectively and unbiasedly. Others you can use from the file Allen just shared when those will be made live.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More